Showing results (991-1000 of 1,020) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|June 1, 2026
Additivity, not synergy, underlies the efficacy of current combination regimens in urothelial cancerNoah M Schlachter, Eric J Miller, Jonathan F Anker, et al.
Cancer Research Communications|May 29, 2026
Transcriptionally informed nucleosome profiling of circulating cell-free DNA predicts breast cancer recurrenceSugiko Watanabe, Kan Etoh, Jun Mitsui, et al.
Cancer Research Communications|May 29, 2026
Associations Between Sugar-sweetened Beverage Intake and Metabolic Syndrome among Postmenopausal Black Women with Obesity and a Family History of Breast CancerStacy M Post, Chiranjeev Dash, Mireille Bright, et al.
Cancer Research Communications|June 4, 2026
Targeting GSTZ1 sensitizes KRAS G12C-mutant lung cancer cells by overcoming glutathione and glycolysis pathway rewiringYi Liao, Xueli Li, Min Liu, et al.
Cancer Research Communications|May 21, 2026
Enhancing Immunotherapeutic Response in Colorectal Cancer with a Neuropilin-1-Targeting Tumor-Penetrating PeptideAtsushi Fukugaki, Shigeo Hisamori, Dean Thumkeo, et al.
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
Cancer Research Communications|October 30, 2023
Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan PatientsWei Tang, Flora Zhang, Jung S Byun, et al.
Cancer Research Communications|April 24, 2026
Hepatic stellate cell-specific METTL3 deficiency promotes hepatocellular carcinoma progression via BMP10-SMAD1/5/8 signalingShanshan Yu, Yiwang Zhang, Yanli Li, et al.
Cancer Research Communications|May 7, 2026
OB-001 Enhances Osimertinib Brain Penetration: Preclinical Pharmacokinetics and Translational Rationale for EGFR-Mutant NSCLC with CNS DiseaseHitesh B Mistry, Jim Millen, Josh Fleet, et al.
Cancer Research Communications|July 30, 2026
Combination AURKA and WEE1 inhibition exhibits efficacy in EGFR or pan-ERBB inhibitor resistant head and neck squamous cell carcinomaFlaviane N Silva, Jong Woo Lee, Theodore T Nguyen, et al.
Pageof 102